{"id":11314,"date":"2018-11-15T17:08:02","date_gmt":"2018-11-15T16:08:02","guid":{"rendered":"https:\/\/www.bm-t.de\/v4\/?p=11314"},"modified":"2021-01-19T17:13:49","modified_gmt":"2021-01-19T16:13:49","slug":"new-investment-round-enables-the-further-development-of-innovative-nanotherapy","status":"publish","type":"post","link":"https:\/\/www.bm-t.de\/en\/2018-en\/new-investment-round-enables-the-further-development-of-innovative-nanotherapy\/","title":{"rendered":"New Investment Round Enables the Further Development of Innovative Nanotherapy"},"content":{"rendered":"<div><strong>A new pri\u00advate investor along with lead investor bm|t, were con\u00advinced of the progress and promise of Smart\u00adDye\u00adLiv\u00adery GmbH from&nbsp;Jena.<\/strong><\/div>\n<div><\/div>\n<div>Erfurt\/Munich\/Jena. Smart\u00adDye\u00adLiv\u00adery GmbH has suc\u00adcess\u00adfully closed a financ\u00ading round with a busi\u00adness angel investor and cur\u00adrent lead investor, bm|t. The young Biotech com\u00adpany from Jena will fur\u00adther develop its inno\u00adv\u00ada\u00adtive nan\u00adotech\u00adnol\u00adogy for life sci\u00adences appli\u00adca\u00adtions. \u201cWith this cap\u00adi\u00adtal, we are well posi\u00adtioned to take our unique nan\u00adoth\u00ader\u00adapy through the next stage of devel\u00adop\u00adment,\u201d said a pleased Dr. Marc Lehmann, Man\u00adag\u00ading Direc\u00adtor of Smart\u00adDye\u00adLiv\u00adery&nbsp;GmbH.<\/div>\n<div>\n<p>Smart\u00adDye\u00adLiv\u00adery devel\u00adops func\u00adtion\u00adal\u00adized nanopar\u00adti\u00adcles in which ther\u00ada\u00adpeu\u00adtic com\u00adpounds are enveloped and safely trans\u00adported to spe\u00adcific organs, which the med\u00adi\u00adcines are tar\u00adget\u00ading. This patented plat\u00adform deliv\u00adery tech\u00adnol\u00adogy can be used for a wide range of ther\u00ada\u00adpeu\u00adtic appli\u00adca\u00adtions and also allows for a unique ther\u00ada\u00adnos\u00adtic use case. Cur\u00adrently the Smart\u00adDye\u00adLiv\u00adery team is focus\u00ading on a ther\u00adapy for sep\u00adsis induced liver fail\u00adure with the goal of reduc\u00ading the mor\u00adtal\u00adity rate of such cases by&nbsp;90%.<\/p>\n<p><strong>About bm\u2011t: <\/strong>Erfurt-based, beteili\u00adgungs\u00adman\u00adage\u00adment Th\u00fcrin\u00adgen (bm|t) \u2013 a sub\u00adsidiary of the Thuringia Devel\u00adop\u00adment Bank, is the first address for invest\u00adments in Thuringia, Ger\u00admany. bm\u2011t cur\u00adrently man\u00adages eight invest\u00adment funds with a total vol\u00adume of 320M EUR. bm\u2011t invests in inno\u00adv\u00ada\u00adtive com\u00adpa\u00adnies with strong growth poten\u00adtial across all sec\u00adtors and all phases of the cor\u00adpo\u00adrate lifecycle.<\/p>\n<p><strong>About Smart\u00adDye\u00adLiv\u00adery GmbH:<\/strong> Smart\u00adDye\u00adLiv\u00adery GmbH devel\u00adops nanopar\u00adti\u00adcle trans\u00adport for ther\u00ada\u00adpeu\u00adtic, diag\u00adnos\u00adtic, and ther\u00ada\u00adnos\u00adtic appli\u00adca\u00adtions. The company\u00b4s goal is to save patients\u00b4 lives by cre\u00adat\u00ading new ther\u00adapy options for med\u00adical con\u00addi\u00adtions that were pre\u00advi\u00adously either untreat\u00adable or extremely dif\u00adfi\u00adcult to&nbsp;treat.<\/p>\n<p>You can find more infor\u00adma\u00adtion about Smart\u00adDye\u00adLiv\u00adery at <a href=\"http:\/\/www.smartdyelivery.de\/\" target=\"_blank\" rel=\"noopener noreferrer\">www.smartdyelivery.de<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>A new pri\u00advate investor along with lead investor bm|t, were con\u00advinced of the progress and promise of Smart\u00adDye\u00adLiv\u00adery GmbH from&nbsp;Jena. Erfurt\/Munich\/Jena. Smart\u00adDye\u00adLiv\u00adery GmbH has suc\u00adcess\u00adfully closed a financ\u00ading round with a busi\u00adness angel investor and cur\u00adrent lead investor, bm|t. The young Biotech com\u00adpany from Jena will fur\u00adther develop its inno\u00adv\u00ada\u00adtive nan\u00adotech\u00adnol\u00adogy for life sci\u00adences applications.&nbsp;[\u2026]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[147],"tags":[],"class_list":["post-11314","post","type-post","status-publish","format-standard","hentry","category-2018-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts\/11314","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/comments?post=11314"}],"version-history":[{"count":0,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts\/11314\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/media?parent=11314"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/categories?post=11314"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/tags?post=11314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}